CIGNA (CI) Stock
Key stats
- Market cap
- $79.43B
- Price / Earnings ratio
- 13.3x
- EPS (TTM)
- $22.78
- Volume
- Loading
- 52-week high
- $318.05
- 52-week low
- $257.85
- Dividend yield
- 2.05%
- Dividend amount (latest)
- $1.56
- EPS vs analyst estimate
- +2.2%Q3 FY25 · $7.83 vs $7.66
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with CI
Recent news

Can Pharmacy Growth Offset Evernorth's Profit Decline in Cigna's Q3?
Can Pharmacy Growth Offset Evernorth's Profit Decline in Cigna's Q3?
CI

What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q3 Earnings
What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q3 Earnings
CI

Mark Cuban Says Public Companies Found They Were ‘Ripped Off’ On Healthcare But Won’t Say So On Earnings Calls
Mark Cuban Says Public Companies Found They Were ‘Ripped Off’ On Healthcare But Won ’t Say So On Earnings Calls
CI

Analysts Estimate Cigna (CI) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Cigna (CI) to Report a Decline in Earnings: What to Look Out for
CI
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 55.48
- MACD 12/26/9
- 3.55
- EMA 9 of MACD
- 4.34
- MACD histogram
- -0.79
- SMA 50
- $287.06
- Price above SMA 50
- EMA 50
- $290.86
- Price above EMA 50
- SMA 200
- $282.57
- Price above SMA 200
- EMA 200
- $282.91
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $7.95 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Can Pharmacy Growth Offset Evernorth's Profit Decline in Cigna's Q3?
Can Pharmacy Growth Offset Evernorth's Profit Decline in Cigna's Q3?
CI

What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q3 Earnings
What Analyst Projections for Key Metrics Reveal About Cigna (CI) Q3 Earnings
CI

Mark Cuban Says Public Companies Found They Were ‘Ripped Off’ On Healthcare But Won’t Say So On Earnings Calls
Mark Cuban Says Public Companies Found They Were ‘Ripped Off’ On Healthcare But Won’t Say So On Earnings Calls
CI

Analysts Estimate Cigna (CI) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Cigna (CI) to Report a Decline in Earnings: What to Look Out for
CI

Why Cigna (CI) is a Top Growth Stock for the Long-Term
Why Cigna (CI) is a Top Growth Stock for the Long-Term
CI

AM Best Assigns Credit Ratings to TMHCC (CI) Insurance SPC Ltd.
AM Best Assigns Credit Ratings to TMHCC (CI) Insurance SPC Ltd.
CI

Here's Why Cigna (CI) is a Strong Value Stock
Here's Why Cigna (CI) is a Strong Value Stock
CI

Here's Why Cigna (CI) is a Strong Growth Stock
Here's Why Cigna (CI) is a Strong Growth Stock
CI

Cigna Reaffirms 2026 Outlook, Targets Complex Care and AI-Driven Growth
Cigna Reaffirms 2026 Outlook, Targets Complex Care and AI-Driven Growth
CI

Cigna to invest $3 billion in multi-year initiative to improve workflow
Cigna to invest $3 billion in multi-year initiative to improve workflow
CI
News tone: automated (AI) classification of the article's content, not a price prediction.
About CIGNA
Cigna is a global health services company dedicated to improving the health, well-being, and peace of mind of those we serve. With more than 180 million customer and patient relationships in more than 30 countries and jurisdictions, we are able to harness actionable insights that address whole-person health and drive better health outcomes.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Brian Case Evanko C.F.A. | President, CEO & Director | 1977 |
| Mr. F. Everett Neville | Executive VP & Special Advisor to the CEO | 1965 |
| Mr. David Michael Cordani | Executive Chairman of the Board | 1965 |
| Ms. Ann M. Dennison | Executive VP & CFO | 1971 |
| Ms. Nicole Susan Jones J.D. | Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer | 1971 |
| Ms. Jamie Kates | Senior VP & Tax and Global Chief Accounting Officer | 1980 |
| Mr. Durga Prasad Koka | Executive Vice President & Global Chief Information Officer | — |
| Mr. Ralph Giacobbe | Senior Vice President of Investor Relations | — |
| Ms. Andrea Nelson | EVP, General Counsel & Corporate Secretary | — |
| Ms. Melissa Skottegaard | Executive Vice President, Chief Marketing & Communications Officer | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 55.48
- MACD 12/26/9
- 3.55
- EMA 9 of MACD
- 4.34
- MACD histogram
- -0.79
- SMA 50
- $287.06
- Price above SMA 50
- EMA 50
- $290.86
- Price above EMA 50
- SMA 200
- $282.57
- Price above SMA 200
- EMA 200
- $282.91
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
7 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $320.00
- Average
- $346.29
- High
- $390.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -11.0 | +17.9 | ||||||||||
| 2022 | -1.6 | +5.3 | +1.1 | +0.2 | +9.0 | -0.4 | +2.7 | +3.7 | -3.7 | +12.5 | +1.2 | +2.4 |
| 2023 | -1.5 | -6.8 | -11.5 | -3.3 | -2.9 | +10.7 | +5.3 | -6.6 | +3.4 | +7.5 | -15.0 | +11.3 |
| 2024 | -3.0 | +9.4 | +9.1 | -1.9 | -3.5 | -3.2 | +6.9 | +8.8 | -5.2 | -9.6 | +6.7 | -18.1 |
| 2025 | +7.2 | +5.6 | +5.6 | +2.7 | -5.5 | +4.9 | -20.0 | +14.7 | -4.1 | -16.2 | +7.2 | +0.6 |
| 2026 | -1.8 | +6.7 | -8.3 | +8.7 | -1.9 | +0.5 | +0.7 | -2.1 | -4.0 | +11.3 | +2.1 |




